** Shares of Australia's Immuron Ltd IMC.AX rise as much
as 6.5% to A$0.082 - set to mark their best day since Nov. 7, if
gains hold
** Biopharma co announces completion of strategic investment
in UK-based Ateria Health Ltd
** Says completed settlement of upfront cash investment of
A$2.6 mln ($1.76 mln) for a 17.5% stake in issued share capital
of Ateria
** Says deal for distribution of irritable bowel syndrome
treatment product JUVIA in Australian and North American
markets, among others
** Stock hits highest level since Nov. 8
** IMC had fallen 23% this year, as of last close
($1 = 1.4799 Australian dollars)
(Reporting by Nausheen Thusoo)
((Nausheen.Thusoo@thomsonreuters.com;))